Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Ösby Urban) "

Sökning: WFRF:(Ösby Urban)

  • Resultat 1-10 av 17
  • [1]2Nästa
Sortera/gruppera träfflistan
  • Hukic, Dzana Sudic, et al. (författare)
  • Cognitive Manic Symptoms in Bipolar Disorder Associated with Polymorphisms in the DAOA and COMT Genes
  • 2013
  • Ingår i: PLoS ONE. - Public Library of Science. - 1932-6203. ; 8:7
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Bipolar disorder is characterized by severe mood symptoms including major depressive and manic episodes. During manic episodes, many patients show cognitive dysfunction. Dopamine and glutamate are important for cognitive processing, thus the COMT and DAOA genes that modulate the expression of these neurotransmitters are of interest for studies of cognitive function. Methodology: Focusing on the most severe episode of mania, a factor was found with the combined symptoms of talkativeness, distractibility, and thought disorder, considered a cognitive manic symptoms (CMS) factor. 488 patients were genotyped, out of which 373 (76%) had talkativeness, 269 (55%) distractibility, and 372 (76%) thought disorder. 215 (44%) patients were positive for all three symptoms, thus showing CMS (Table 1). As population controls, 1,044 anonymous blood donors (ABD) were used. Case-case and case-control design models were used to investigate genetic associations between cognitive manic symptoms in bipolar 1 disorder and SNPs in the COMT and DAOA genes. Results: The finding of this study was that cognitive manic symptoms in patients with bipolar 1 disorder was associated with genetic variants in the DAOA and COMT genes. Nominal association for DAOA SNPs and COMT SNPs to cognitive symptoms factor in bipolar 1 disorder was found in both allelic (Table 2) and haplotypic (Table 3) analyses. Genotypic association analyses also supported our findings. However, only one association, when CMS patients were compared to ABD controls, survived correction for multiple testing by max (T) permutation. Data also suggested interaction between SNPs rs2391191 in DAOA and rs5993883 in COMT in the case-control model. Conclusion: Identifying genes associated with cognitive functioning has clinical implications for assessment of prognosis and progression. Our finding are consistent with other studies showing genetic associations between the COMT and DAOA genes and impaired cognition both in psychiatric disorders and in the general population.
  • Amare, Azmeraw T, et al. (författare)
  • Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.
  • 2017
  • Ingår i: JAMA psychiatry. - 2168-6238. ; 75:1, s. 65-74
  • Tidskriftsartikel (refereegranskat)abstract
    • Lithium is a first-line mood stabilizer for the treatment of bipolar affective disorder (BPAD). However, the efficacy of lithium varies widely, with a nonresponse rate of up to 30%. Biological response markers are lacking. Genetic factors are thought to mediate treatment response to lithium, and there is a previously reported genetic overlap between BPAD and schizophrenia (SCZ).To test whether a polygenic score for SCZ is associated with treatment response to lithium in BPAD and to explore the potential molecular underpinnings of this association.A total of 2586 patients with BPAD who had undergone lithium treatment were genotyped and assessed for long-term response to treatment between 2008 and 2013. Weighted SCZ polygenic scores were computed at different P value thresholds using summary statistics from an international multicenter genome-wide association study (GWAS) of 36 989 individuals with SCZ and genotype data from patients with BPAD from the Consortium on Lithium Genetics. For functional exploration, a cross-trait meta-GWAS and pathway analysis was performed, combining GWAS summary statistics on SCZ and response to treatment with lithium. Data analysis was performed from September 2016 to February 2017.Treatment response to lithium was defined on both the categorical and continuous scales using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder score. The effect measures include odds ratios and the proportion of variance explained.Of the 2586 patients in the study (mean [SD] age, 47.2 [13.9] years), 1478 were women and 1108 were men. The polygenic score for SCZ was inversely associated with lithium treatment response in the categorical outcome, at a threshold P < 5 × 10-2. Patients with BPAD who had a low polygenic load for SCZ responded better to lithium, with odds ratios for lithium response ranging from 3.46 (95% CI, 1.42-8.41) at the first decile to 2.03 (95% CI, 0.86-4.81) at the ninth decile, compared with the patients in the 10th decile of SCZ risk. In the cross-trait meta-GWAS, 15 genetic loci that may have overlapping effects on lithium treatment response and susceptibility to SCZ were identified. Functional pathway and network analysis of these loci point to the HLA antigen complex and inflammatory cytokines.This study provides evidence for a negative association between high genetic loading for SCZ and poor response to lithium in patients with BPAD. These results suggest the potential for translational research aimed at personalized prescribing of lithium.
  • Hou, Liping, et al. (författare)
  • Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.
  • 2016
  • Ingår i: Human molecular genetics. - 1460-2083. ; 25:15, s. 3383-94
  • Tidskriftsartikel (refereegranskat)abstract
    • Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behavior. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of >9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ∼2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, p = 5.87 × 10(-9); odds ratio = 1.12) and markers within ERBB2 (rs2517959, p = 4.53 × 10(-9); odds ratio = 1.13). No significant X-chromosome associations were detected and X-linked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.
  • Hukic, Dzana Sudic, et al. (författare)
  • Troponin T levels associated with genetic variants in NOTCH2 and MTNR1B in women with psychosis
  • 2017
  • Ingår i: Psychiatry Research. - Elsevier. - 0165-1781. ; 250, s. 217-220
  • Tidskriftsartikel (refereegranskat)abstract
    • Psychosis patients have increased prevalence of metabolic disorders, which increase the risk for cardiovascular disease. Elevated troponin T level is an early biomarker of cardiovascular damage. We tested for association between troponin T levels and genetic risk variants of elevated blood glucose level in psychosis. Glucose and troponin T levels correlated positively. MTNR1B rs10830963 and NOTCH2 rs10923931 associated with troponin T levels in women, adjusted for glucose levels. These findings may indicate metabolic genetic influences on troponin T levels among women with psychosis.
  • Kalman, Janos L, et al. (författare)
  • Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.
  • 2019
  • Ingår i: Bipolar disorders. - 1399-5618. ; 21:1, s. 68-75
  • Tidskriftsartikel (refereegranskat)abstract
    • Bipolar disorder (BD) with early disease onset is associated with an unfavorable clinical outcome and constitutes a clinically and biologically homogenous subgroup within the heterogeneous BD spectrum. Previous studies have found an accumulation of early age at onset (AAO) in BD families and have therefore hypothesized that there is a larger genetic contribution to the early-onset cases than to late onset BD. To investigate the genetic background of this subphenotype, we evaluated whether an increased polygenic burden of BD- and schizophrenia (SCZ)-associated risk variants is associated with an earlier AAO in BD patients.A total of 1995 BD type 1 patients from the Consortium of Lithium Genetics (ConLiGen), PsyCourse and Bonn-Mannheim samples were genotyped and their BD and SCZ polygenic risk scores (PRSs) were calculated using the summary statistics of the Psychiatric Genomics Consortium as a training data set. AAO was either separated into onset groups of clinical interest (childhood and adolescence [≤18 years] vs adulthood [>18 years]) or considered as a continuous measure. The associations between BD- and SCZ-PRSs and AAO were evaluated with regression models.BD- and SCZ-PRSs were not significantly associated with age at disease onset. Results remained the same when analyses were stratified by site of recruitment.The current study is the largest conducted so far to investigate the association between the cumulative BD and SCZ polygenic risk and AAO in BD patients. The reported negative results suggest that such a polygenic influence, if there is any, is not large, and highlight the importance of conducting further, larger scale studies to obtain more information on the genetic architecture of this clinically relevant phenotype.
  • Laursen, Thomas Munk, et al. (författare)
  • Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries
  • 2013
  • Ingår i: PloS one. - 1932-6203. ; 8:6, s. e67133
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: Excess mortality from diseases and medical conditions (natural death) in persons with psychiatric disorders has been extensively reported. Even in the Nordic countries with well-developed welfare systems, register based studies find evidence of an excess mortality. In recent years, cardiac mortality and death by diseases of the circulatory system has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease. The aim of this study was to compare the mortality by diseases of the circulatory system among patients with bipolar disorder or schizophrenia in the three Nordic countries Denmark, Sweden, and Finland. Furthermore, the aim was to examine and compare life expectancy among these patients. Cause specific Standardized Mortality Rates (SMRs) were calculated for each specific subgroup of mortality. Life expectancy was calculated using Wiesler's method.RESULTS: The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes. SMR was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark. Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter.CONCLUSION: Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy. An evaluation of the reasons for these increased mortality rates should be prioritized when planning healthcare in the coming years.
  • Ludvigsson, Jonas F., et al. (författare)
  • Coeliac disease and risk of mood disorders : a general population-based cohort study
  • 2007
  • Ingår i: Journal of Affective Disorders. - Amsterdam : Elsevier Biomedical. - 0165-0327. ; 99:1, s. 117-126
  • Tidskriftsartikel (övrigt vetenskapligt)abstract
    • Background Earlier research has indicated a positive association between coeliac disease (CD) and some mental disorders. Studies on CD and depression have inconsistent findings and we know of no study of CD and the risk of bipolar disorder (BD). Methods We used Cox regression to investigate the risk of subsequent mood disorders (MD); depression and BD in 13,776 individuals with CD and 66,815 age- and sex-matched reference individuals in a general population-based cohort study in Sweden. We also studied the association between prior MD and CD through conditional logistic regression. Results CD was associated with an increased risk of subsequent depression (Hazard ratio (HR)<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />1.8; 95% CI<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />1.6–2.2; p<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />&lt;<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />0.001, based on 181 positive events in individuals with CD and 529 positive events in reference individuals). CD was not associated with subsequent BD (HR<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />1.1; 95% CI<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />0.7–1.7; p<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />0.779, based on 22 and 99 positive events). Individuals with prior depression (OR<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />2.3; 95% CI<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />2.0–2.8; p<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />&lt;<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />0.001) or prior BD (OR<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />1.7; 95% CI<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />1.2–2.3; p<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />=<img src="http://www.jad-journal.com/webfiles/images/transparent.gif" />0.001) were at increased risk of a subsequent diagnosis of CD. Limitations Study participants with CD and MD may have more severe disease than the average patient with these disorders since they were identified through a hospital-based register. Conclusions CD is positively associated with subsequent depression. The risk increase for CD in individuals with prior depression and BD may be due to screening for CD among those with MD.
  • Olsson, Eric, et al. (författare)
  • Diabetes and glucose disturbances in patients with psychosis in Sweden
  • 2015
  • Ingår i: BMJ Open Diabetes Research & Care. - 2052-4897. ; 3
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE:The objectives of this study were to (1) analyze the prevalence of diabetes, prediabetes, and antidiabetic medication in patients with psychosis compared with control subjects and (2) determine what factors in patients with psychosis were associated with antidiabetic medication.METHOD:We studied 977 patients with psychosis recruited from outpatient clinics in Stockholm County, Sweden, and they were compared with 3908 non-psychotic control subjects for fasting plasma glucose levels; prevalence of diabetes, prediabetes, antidiabetic treatment, and tobacco use; and blood pressure, weight, height, and waist circumference. Group differences were evaluated with analysis of variance and χ(2) test, and factors associated with antidiabetic treatment were evaluated with logistic regression.RESULTS:Diabetes was observed in 94 (10%) patients with psychosis, 2.7 times the prevalence observed in control subjects. Among patients with psychosis, 87 (10%) had prediabetes (fasting glucose, 6.1-6.9 mmol/L) compared with 149 (3.8%) control subjects. Most patients with psychosis (77%) who had prediabetes fulfilled criteria for metabolic syndrome. In patients with psychosis, both lipid-lowering medication and fasting glucose were significantly associated with antidiabetic treatment. There was no significant relation between antidiabetic treatment and lifestyle factors such as smoking or degree of psychiatric illness.CONCLUSIONS:The high prevalence of impaired fasting glucose and metabolic syndrome in patients with psychosis warrants further clinical research in preventing or delaying the onset of diabetes in these patients by pharmacotherapy and/or lifestyle intervention.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 17
  • [1]2Nästa
fritt online (2)
Typ av publikation
tidskriftsartikel (15)
samlingsverk (redaktörskap) (1)
doktorsavhandling (1)
Typ av innehåll
refereegranskat (15)
övrigt vetenskapligt (2)
Osby, U, (11)
Lavebratt, Catharina (7)
Frisen, Louise (7)
Landén, Mikael, 1966 ... (6)
Backlund, Lena (6)
Landen, M, (5)
visa fler...
Cichon, Sven, (5)
McMahon, Francis J., (5)
Rietschel, Marcella, (5)
Schofield, Peter R., (5)
Baune, Bernhard T. (5)
Rouleau, Guy A. (5)
Heilbronner, Urs (5)
Degenhardt, Franzisk ... (5)
Bellivier, Frank (5)
Biernacka, Joanna M (5)
Cervantes, Pablo (5)
Cruceanu, Cristiana (5)
Czerski, Piotr M (5)
Étain, Bruno (5)
Forstner, Andreas J (5)
Fullerton, Janice M (5)
Grigoroiu-Serbanescu ... (5)
Hauser, Joanna (5)
Herms, Stefan (5)
Hoffmann, Per (5)
Novak, T (4)
Nothen, MM (4)
Monteleone, Palmiero (4)
Konig, B (4)
Hou, Liping (4)
Shekhtman, Tatyana (4)
Adli, Mazda (4)
Akula, Nirmala (4)
Ardau, Raffaella (4)
Arias, Bárbara (4)
Aubry, Jean-Michel (4)
Bhattacharjee, Abesh ... (4)
Bengesser, Susanne (4)
Birner, Armin (4)
Brichant-Petitjean, ... (4)
Chillotti, Caterina (4)
Dayer, Alexandre (4)
Del Zompo, Maria (4)
DePaulo, J Raymond (4)
Falkai, Peter (4)
Frye, Mark A (4)
Gard, Sébastien (4)
Garnham, Julie S (4)
Goes, Fernando S (4)
visa färre...
Karolinska Institutet (15)
Göteborgs universitet (6)
Lunds universitet (5)
Uppsala universitet (5)
Umeå universitet (1)
Örebro universitet (1)
Engelska (17)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (17)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy